Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

'Roll Call' Solicits Strong Opinions On Health Reform
Roll Call published a special section today that pulls together opinion pieces from 20 major players from all corners of the health care debate, including Tom Daschle, Michael Tanner, Dick Gephardt and Tommy Thompson and Newt Gingrich and Jim Frogue.
generic viagra online
British Medical Journal Examines Recent Progress In Treating Neglected Diseases
The British Medical Journal examines the outcome of the Drugs for Neglected Diseases initiative meeting held in Nairobi, Kenya, last week. More than 200 international health experts came together to discuss finding therapies for such diseases as visceral leishmaniasis, Chagas disease and sleeping sickness. "Current treatments are often toxic, prohibitively expensive, or difficult to administer in countries with limited res," and "[d]rug companies have little incentive to develop treatments for neglected diseases that mainly affect poor people," the journal writes.
News of the day
Economic Crisis Already Crippling Global HIV/AIDS Treatment, Prevention Programs, UNAIDS, World Bank Report Says
Global HIV/AIDS prevention and treatment programs are already feeling the effects of the global economic crisis, according to a report (pdf) released Monday by UNAIDS and the World Bank, AFP/Google.com reports (7/6).
Medical Devices

Benefits Of Anti-TB Plan Would Dwarf Costs In Sub-Saharan Africa

A diverse international network has proposed to significantly increase the res devoted to fighting tuberculosis, the second most deadly of the world"s infectious diseases. The "Global Plan to Stop TB" would step up use of treatments and techniques that have proved effective in fighting the disease, but would the benefits of the additional effort outweigh the costs? In sub-Saharan Africa, the answer is yes, according to an analysis published today on the Health Affairs Web site. In this region, when the Global Plan is compared to continuing the current anti-TB strategy, the benefits of the Global Plan would outweigh its costs by a ratio of 9 to 1, say Ramanan Laxminarayan, a senior fellow at Res for the Future in Washington, D.C., and coauthors. However, the benefit-to-cost ratio of the Global Plan would vary from area to area: the plan"s benefits would unambiguously outweigh the costs in only 12 of the 22 countries with the highest TB-related burden: the nine high-burden countries in Africa plus Afghanistan, Pakistan, and Russia. ÷ Link to÷ the article by Laxminarayan and coauthors. Health Affairs is pleased to make this article freely accessible for two weeks. Health Affairs


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009